AVMAPKI™ FAKZYNJA™ CO-PACK (avutometinib capsules; defactinib tablets,) FDA Approved for the Treatment of Adult Patients with KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer who have Received Prior Systemic Therapy, Available at Biologics by McKesson
Biologics by McKesson was selected as a limited specialty pharmacy provider for AVMAPKI FAKZYNJA CO-PACK, approved for adults with KRAS-mutated recurrent low-grade serous ovarian cancer after prior systemic therapy.